ATE109003T1 - Therapeutisches mittel gegen pollakiurie, harndrang oder harninkontinenz, das alpha-phenyl- alpha-pyridylalkan-carbonsäurederivate enthält. - Google Patents

Therapeutisches mittel gegen pollakiurie, harndrang oder harninkontinenz, das alpha-phenyl- alpha-pyridylalkan-carbonsäurederivate enthält.

Info

Publication number
ATE109003T1
ATE109003T1 AT91105753T AT91105753T ATE109003T1 AT E109003 T1 ATE109003 T1 AT E109003T1 AT 91105753 T AT91105753 T AT 91105753T AT 91105753 T AT91105753 T AT 91105753T AT E109003 T1 ATE109003 T1 AT E109003T1
Authority
AT
Austria
Prior art keywords
alpha
therapeutic agent
uricness
pyridylalkan
urine
Prior art date
Application number
AT91105753T
Other languages
English (en)
Inventor
Masaaki Tomoi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE109003T1 publication Critical patent/ATE109003T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pyridine Compounds (AREA)
AT91105753T 1990-04-18 1991-04-11 Therapeutisches mittel gegen pollakiurie, harndrang oder harninkontinenz, das alpha-phenyl- alpha-pyridylalkan-carbonsäurederivate enthält. ATE109003T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10390390 1990-04-18

Publications (1)

Publication Number Publication Date
ATE109003T1 true ATE109003T1 (de) 1994-08-15

Family

ID=14366388

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91105753T ATE109003T1 (de) 1990-04-18 1991-04-11 Therapeutisches mittel gegen pollakiurie, harndrang oder harninkontinenz, das alpha-phenyl- alpha-pyridylalkan-carbonsäurederivate enthält.

Country Status (11)

Country Link
US (1) US5202331A (de)
EP (1) EP0452809B1 (de)
JP (1) JP2500821B2 (de)
KR (1) KR100190823B1 (de)
AT (1) ATE109003T1 (de)
AU (1) AU641747B2 (de)
CA (1) CA2040680A1 (de)
DE (1) DE69103068T2 (de)
DK (1) DK0452809T3 (de)
TW (1) TW214546B (de)
ZA (1) ZA912589B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998002432A1 (en) * 1996-07-16 1998-01-22 Takeda Chemical Industries, Ltd. Bicyclic compounds for controlling micturition
WO2001087298A1 (fr) * 2000-05-15 2001-11-22 Rohto Pharmaceutical Co., Ltd. Preparation liquide a base d'eau

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5980664A (ja) * 1982-09-30 1984-05-10 Fujisawa Pharmaceut Co Ltd α−アリ−ル−α−ピリジル脂肪酸誘導体およびその製法
US4857535A (en) * 1986-01-09 1989-08-15 United Pharmaceuticals Anti-spasmodic agents having a heterocyclic ring
DE3601196A1 (de) * 1986-01-17 1987-07-23 Merck Patent Gmbh 1,4-dihydropyridine
US4957941A (en) * 1987-11-16 1990-09-18 United Pharmaceuticals, Inc. Anti-spasmdoic agents having an acetylenic bond
US5066680A (en) * 1989-02-14 1991-11-19 Fujisawa Pharmaceutical Co., Ltd. Novel substituted-acetamide compound and a process for the preparation thereof

Also Published As

Publication number Publication date
AU641747B2 (en) 1993-09-30
CA2040680A1 (en) 1991-10-19
AU7506591A (en) 1991-10-24
EP0452809A3 (en) 1992-04-15
EP0452809B1 (de) 1994-07-27
DE69103068T2 (de) 1995-01-05
JP2500821B2 (ja) 1996-05-29
KR100190823B1 (ko) 1999-06-01
DK0452809T3 (da) 1994-09-05
TW214546B (de) 1993-10-11
EP0452809A2 (de) 1991-10-23
ZA912589B (en) 1992-01-29
DE69103068D1 (de) 1994-09-01
KR910018026A (ko) 1991-11-30
JPH059118A (ja) 1993-01-19
US5202331A (en) 1993-04-13

Similar Documents

Publication Publication Date Title
SE9604786D0 (sv) New compounds
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
FI890689A0 (fi) 3-alkenyl-1-azabicyklo-/3.2.0/ -hept-2-en-2-karboxylsyrafoereningar.
BR0211228A (pt) Composto, composição farmacêutica e seus usos
DK0378255T3 (da) 2-aminopyrimidinoderivater
FI921522A0 (fi) Pyrazolopyridinfoerening och foerfarande foer dess framstaellning.
ATE110071T1 (de) Pyridazinon-derivate und diese enthaltende pharmazeutische zubereitungen.
ATE38991T1 (de) In 2-stellung substituierte 1,3propyledendephosphonat-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
ATE161531T1 (de) Acridine-1,8-dionderivate als therapeutisches mittel
DK0570294T3 (da) 2-formylpyridinthiosemicarbazonderivater, deres fremstilling og deres anvendelse som antitumormiddel
NO905620L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
UA42733C2 (uk) Похідні біснафталіміду та їх фармацевтично прийнятні кислотно-адитивні солі, фармацевтична композиція з цитотоксичною активністю, яка їх містить
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
ATE109003T1 (de) Therapeutisches mittel gegen pollakiurie, harndrang oder harninkontinenz, das alpha-phenyl- alpha-pyridylalkan-carbonsäurederivate enthält.
IL70797A (en) Triazole derivatives,their preparation and pharmaceutical and agricultural compositions containing them
ZA928876B (en) Thiazole derivatives.
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
NO20013601L (no) Nye morfolinobenzamidsalter
GB8608893D0 (en) D-nor-7-ergoline derivatives
IE37288B1 (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
DK644487D0 (da) Farmaceutisk praeparat indeholdende en 2-oxo-imidazolidinforbindelse
ATE109454T1 (de) Catecholaminester.
EP0272849A3 (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases
IT1245390B (it) Composizione farmaceutica ad attivita' antivirale

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee